Related Experiment Video
Updated: Feb 4, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Mutations of genes including DNMT3A detected by next-generation sequencing in thyroid cancer
Ling-Chuan Guo, Wei-Dong Zhu1, Xiang-Yuan Ma2
1a Department of Pathology , Hospital of Soochow University , Suzhou , China.
Abstract:
More than 90% of thyroid cancer belongs to the papillary and follicular thyroid carcinomas based on pathological subtypes. Papillary and follicular thyroid carcinoma are generally associated with a good prognosis. In contrast, other pathological subtypes such as poorly-differentiated and anaplastic thyroid carcinoma (PDTC and ATC) have a poor clinical outcome with a short life expectancy. To identify the genetic variations and biomarkers that may potentially distinguish the aggressive form of thyroid cancer, we performed a retrospective analysis of the formalin-fixed paraffin-embedded tumor samples from 50 patients who mainly displayed aggressive thyroid cancer using next-generation sequencing of 416 solid tumor-related genes. We adopted extensive bioinformatic analysis to vigorously remove germline single-nucleotide polymorphism and systematic sequencing errors, and report here that mutation in DNMT3A gene was significantly enriched in patients with PDTC or ATC.
Related Concept Videos
Mutation, Gene Flow, and Genetic Drift
Mutations
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Cancers Originate from Somatic Mutations in a Single Cell
Export of Mitochondrial and Chloroplast Genes
Viral Mutations

